The estimated Net Worth of Bradley Allen Kreger is at least $1.7 Milion dollars as of 22 February 2022. Mr. Kreger owns over 7,753 units of Standard BioTools Inc stock worth over $350,565 and over the last 6 years he sold FLDM stock worth over $0. In addition, he makes $1,352,300 as Senior Vice President i Global Operations at Standard BioTools Inc.
Bradley has made over 12 trades of the Standard BioTools Inc stock since 2019, according to the Form 4 filled with the SEC. Most recently he exercised 7,753 units of FLDM stock worth $28,764 on 22 February 2022.
The largest trade he's ever made was exercising 57,752 units of Standard BioTools Inc stock on 20 May 2021 worth over $214,260. On average, Bradley trades about 8,402 units every 59 days since 2019. As of 22 February 2022 he still owns at least 94,492 units of Standard BioTools Inc stock.
You can see the complete history of Mr. Kreger stock trades at the bottom of the page.
Bradley Allen Kreger serves as Senior Vice President, Global Operations of the Company. Mr. Kreger was Senior Director, Operations, Clinical Sequencing Division at Thermo Fisher Scientific, a life sciences company. From 1995 to December 2016, Mr. Kreger held various staff and management positions at Affymetrix, a biotechnology company, including VP, Reagent Manufacturing & Global Process Engineering, Senior Director, Global Process Engineering and Manufacturing Science, and Director, Global Process Engineering and Manufacturing Science. Mr. Kreger received a MBA from Western Governors University and a B.S. in Biotechnology and Business from Charter Oak State College.
As the Senior Vice President i Global Operations of Standard BioTools Inc, the total compensation of Bradley Kreger at Standard BioTools Inc is $1,352,300. There are 3 executives at Standard BioTools Inc getting paid more, with Stephen Linthwaite having the highest compensation of $3,713,060.
Bradley Kreger is 45, he's been the Senior Vice President i Global Operations of Standard BioTools Inc since 2018. There are 13 older and no younger executives at Standard BioTools Inc. The oldest executive at Standard BioTools Inc is Vikram Jog, 65, who is the Chief Financial Officer.
Bradley's mailing address filed with the SEC is C/O FLUIDIGM CORPORATION, 2 TOWER PLACE, STE 2000, SOUTH SAN FRANCISCO, CA, 94080.
Over the last 14 years, insiders at Standard BioTools Inc have traded over $29,087,682 worth of Standard BioTools Inc stock and bought 4,143,303 units worth $24,269,186 . The most active insiders traders include Easterly Partners Llcle Par..., Capital Strategies, L.P.Lev... oraz Samuel D Colella. On average, Standard BioTools Inc executives and independent directors trade stock every 9 days with the average trade being worth of $72,208. The most recent stock trade was executed by Nicolas Barthelemy on 1 April 2022, trading 20,993 units of FLDM stock currently worth $78,514.
Fluidigm focuses on the most pressing needs in translational and clinical research, including cancer, immunology, and immunotherapy. Using proprietary CyTOF® and microfluidics technologies, it develops, manufactures, and markets multi-omic solutions to drive meaningful insights in health and disease, identify biomarkers to inform decisions, and accelerate the development of more effective therapies. Its customers are leading academic, government, pharmaceutical, biotechnology, plant and animal research, and clinical laboratories worldwide. Together with them, the Company strives to increase the quality of life for all.
Standard BioTools Inc executives and other stock owners filed with the SEC include: